-+ 0.00%
-+ 0.00%
-+ 0.00%

Carlsmed Reports Q4 2025 Revenue Of ~$15.2M; Full-Year 2025 Revenue Of ~$50.5M

Benzinga·01/12/2026 13:16:27
Listen to the news

Fourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024

Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024

CARLSBAD, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced preliminary and unaudited revenue for the fourth quarter and year ended December 31, 2025.

Preliminary Q4 & FY 2025 Revenue Results

  • Fourth quarter 2025 revenue was approximately $15.2 million, an approximate 61% increase compared to the fourth quarter 2024.
  • Full year 2025 revenue was approximately $50.5 million, an approximate 86% increase compared to the full year 2024.